Evidence map›Paper›PMID 34117280›Full record

ArticleScientific reports2021

AMPK activates Parkin independent autophagy and improves post sepsis immune defense against secondary bacterial lung infections.

Nathaniel B Bone, Eugene J Becker, Maroof Husain, Shaoning Jiang, Anna A Zmijewska, Dae-Won Park, Balu Chacko, Victor Darley-Usmar, Murielle Grégoire, Jean-Marc Tadie and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. TheCells · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. ZKSCAN3 in severe bacterial lung infection and sepsis-induced immunosuppression.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Nathaniel B Bone *Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Eugene J Becker *Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Maroof HusainDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Shaoning JiangDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Anna A ZmijewskaDepartment of Nephrology, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Dae-Won ParkDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Balu ChackoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Victor Darley-UsmarDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Murielle GrégoireINSERM, EFS Bretagne, UMR U1236, Université Rennes, Rennes, France.
Jean-Marc TadieINSERM, EFS Bretagne, UMR U1236, Université Rennes, Rennes, France.
Victor J ThannickalDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA.
Jaroslaw W ZmijewskiDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294-0012, USA. zmijewsk@uab.edu.
University of Alabama at Birmingham · USInserm · FR

Funding

Therapeutic Targeting of the Myofibroblast in Fibrotic Lung DiseaseP01HL114470 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI THANNICKAL, VICTOR J. · 2013 to 2022
$17.8M
AMPK in the Development and Resolution of Lung FibrosisR01HL139617 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Victor J. Thannickal, Jaroslaw Waldemar Zmijewski · 2019 to 2026
$4.4M
NHLBI NIH HHS P01 HL114470NHLBI NIH HHS R01 HL139617
6 · The paper itself

Abstract

Metabolic and bioenergetic plasticity of immune cells is essential for optimal responses to bacterial infections. AMPK and Parkin ubiquitin ligase are known to regulate mitochondrial quality control mitophagy that prevents unwanted inflammatory responses. However, it is not known if this evolutionarily conserved mechanism has been coopted by the host immune defense to eradicate bacterial pathogens and influence post-sepsis immunosuppression. Parkin, AMPK levels, and the effects of AMPK activators were investigated in human leukocytes from sepsis survivors as well as wild type and Park2

Indexed as

AutophagyAMP-Activated Protein KinasesAnimalsBacterial InfectionsHumansLung DiseasesMiceMice, Inbred C57BLSepsisUbiquitin-Protein LigasesAMP-Activated Protein Kinasesparkin proteinUbiquitin-Protein Ligases

Identifiers

PMID34117280
PMCPMC8196038
OpenAlexW3165954305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.